Tients with increased LV thickness (LV mean thickness 12 mm), defined as

Tients with increased LV thickness (LV mean thickness 12 mm), defined as cardiac amyloidosis, were included for final analysis. Decompensated CA patients were defined as New York Heart Association (NYHA) functional class .2 and exacerbation of dyspnea within the last 6 months [12]. Thirty healthy volunteers recruited from the local hospital staff matched with age and gender to the patient cohort served as controls. Patients were followed up by clinical visit or telephone call for a median of 345 days (quartiles: 141?46 days).Standard Echocardiographic MeasurementsA standard echocardiographic examination was performed (GE Vingmed Vivid 7, Horten, Norway). Left ventricular end-Sudan I Diastolic (LVEDD), end-systolic dimensions (LVESD) end-diastolic thickness of the posterior wall (LVPWd) and the septum (IVSd), LVMyocardial Strain in Systemic Amyloidosis PatientsTable 2. Cardiac related 23727046 clinical data and standard echocardiographic characteristics according to clinical staging.Controls n = 30 Male ( ) Age (years) BMI (kg/m ) Heart rate (beats/min) Systolic blood pressure (mmHg) Diastolic blood pressure (mmHg) Mean NYHA class Medication Digitalis Angiotensin converting enzyme inhibitor Angiotensin-II receptor typy-1 blocker Aldosterone inhibitor Beta blocker LV end-diastolic dimension (mm) LV mean thickness (mm) LA diameter (mm) RV end-diastolic dimension (mm) RA area (cm2) RV free wall thickness (mm) InterMedChemExpress Lecirelin atrial septum thickness (mm) LV mass index (g/m2) LV stroke volume (ml) LV fractional shortening ( ) LV ejection fraction ( ) Septal mitral annular displacement (mm) Lateral mitral annular displacement (mm) TAPSE (mm) E/A E/E’ DT (ms) 5064 961 3563 3465 1563 461 461 85615 78619 3767 6666 1261 1462 2363 1.160.3 1063Compensated group n = 18 61 66610 23.463.0 7368 126618 74611 1.560.3*Decompensated group n = 26 54 65611 24.463.4 84612* 112622 71613 3.160.4*{60 6169 24.663.0 69610 132611 82692 (11 ) 8 (44 ) 2 (11 ) 1 (6 ) 6 (33 ) 4367* 1363* 4069* 3566 1765 561* 561 127649 51619* 3467 6367 763* 1063* 1665* 1.260.7 1769*6 (23 ) 8 (31 ) 5 (19 ) 5 (19 ) 10 (39 ) 4468* 1564*{ 4468* 3666 2166*{ 661*{ 662*{ 156659* 46616* 2568*{ 52612*{ 563*{ 763*{ 1364*{ 1.860.9*{ 25610*{ 148648*{*P,0.05 vs. Controls; { P,0.05 vs. Compensated group. BMI: body mass index; NYHA: New York Heart Association; LV: left ventricle; LA: left atrial; RV: right ventricular; RA: right atrial; TAPSE: tricuspid annular plane systolic excursion; E/A: early diastolic filling velocity (E) to late diastolic filling velocity (A) ratio; E/E’: mitral inflow velocity (E) to tissue Doppler E’ ratio; DT: deceleration time of early filling. doi:10.1371/journal.pone.0056923.tstroke volume (SV), and fractional shortening (FS) were measured using standard M-mode in parasternal LV long axis views. Left atrial (LA) end-systolic diameter (LAD) was measured with 2D mode from the parasternal long-axis view. LV mean thickness was calculated as: (LVPWd+IVSd)/2. From the apical 4-chamber view, right ventricular end-diastolic dimension (RVEDD) and right ventricular (RV) free wall end-diastolic maximal thickness (RVd), end-systolic right atrium area (RAA) and end-systolic interatrial septum maximal thickness (IASd) were measured. LV EF was measured with the biplane Simpson method in apical 4- and 2-chamber views, septal and lateral mitral annular displacement (MAD_sept and MAD_lat) and tricuspid plane annular systolic excursion (TAPSE) were measured by M-mode in apical 4-chamber view. Pulsed-wave Doppler was.Tients with increased LV thickness (LV mean thickness 12 mm), defined as cardiac amyloidosis, were included for final analysis. Decompensated CA patients were defined as New York Heart Association (NYHA) functional class .2 and exacerbation of dyspnea within the last 6 months [12]. Thirty healthy volunteers recruited from the local hospital staff matched with age and gender to the patient cohort served as controls. Patients were followed up by clinical visit or telephone call for a median of 345 days (quartiles: 141?46 days).Standard Echocardiographic MeasurementsA standard echocardiographic examination was performed (GE Vingmed Vivid 7, Horten, Norway). Left ventricular end-diastolic (LVEDD), end-systolic dimensions (LVESD) end-diastolic thickness of the posterior wall (LVPWd) and the septum (IVSd), LVMyocardial Strain in Systemic Amyloidosis PatientsTable 2. Cardiac related 23727046 clinical data and standard echocardiographic characteristics according to clinical staging.Controls n = 30 Male ( ) Age (years) BMI (kg/m ) Heart rate (beats/min) Systolic blood pressure (mmHg) Diastolic blood pressure (mmHg) Mean NYHA class Medication Digitalis Angiotensin converting enzyme inhibitor Angiotensin-II receptor typy-1 blocker Aldosterone inhibitor Beta blocker LV end-diastolic dimension (mm) LV mean thickness (mm) LA diameter (mm) RV end-diastolic dimension (mm) RA area (cm2) RV free wall thickness (mm) Interatrial septum thickness (mm) LV mass index (g/m2) LV stroke volume (ml) LV fractional shortening ( ) LV ejection fraction ( ) Septal mitral annular displacement (mm) Lateral mitral annular displacement (mm) TAPSE (mm) E/A E/E’ DT (ms) 5064 961 3563 3465 1563 461 461 85615 78619 3767 6666 1261 1462 2363 1.160.3 1063Compensated group n = 18 61 66610 23.463.0 7368 126618 74611 1.560.3*Decompensated group n = 26 54 65611 24.463.4 84612* 112622 71613 3.160.4*{60 6169 24.663.0 69610 132611 82692 (11 ) 8 (44 ) 2 (11 ) 1 (6 ) 6 (33 ) 4367* 1363* 4069* 3566 1765 561* 561 127649 51619* 3467 6367 763* 1063* 1665* 1.260.7 1769*6 (23 ) 8 (31 ) 5 (19 ) 5 (19 ) 10 (39 ) 4468* 1564*{ 4468* 3666 2166*{ 661*{ 662*{ 156659* 46616* 2568*{ 52612*{ 563*{ 763*{ 1364*{ 1.860.9*{ 25610*{ 148648*{*P,0.05 vs. Controls; { P,0.05 vs. Compensated group. BMI: body mass index; NYHA: New York Heart Association; LV: left ventricle; LA: left atrial; RV: right ventricular; RA: right atrial; TAPSE: tricuspid annular plane systolic excursion; E/A: early diastolic filling velocity (E) to late diastolic filling velocity (A) ratio; E/E’: mitral inflow velocity (E) to tissue Doppler E’ ratio; DT: deceleration time of early filling. doi:10.1371/journal.pone.0056923.tstroke volume (SV), and fractional shortening (FS) were measured using standard M-mode in parasternal LV long axis views. Left atrial (LA) end-systolic diameter (LAD) was measured with 2D mode from the parasternal long-axis view. LV mean thickness was calculated as: (LVPWd+IVSd)/2. From the apical 4-chamber view, right ventricular end-diastolic dimension (RVEDD) and right ventricular (RV) free wall end-diastolic maximal thickness (RVd), end-systolic right atrium area (RAA) and end-systolic interatrial septum maximal thickness (IASd) were measured. LV EF was measured with the biplane Simpson method in apical 4- and 2-chamber views, septal and lateral mitral annular displacement (MAD_sept and MAD_lat) and tricuspid plane annular systolic excursion (TAPSE) were measured by M-mode in apical 4-chamber view. Pulsed-wave Doppler was.